Back | Next |
home / stock / gblx / gblx message board
Subject | By | Source | When |
---|---|---|---|
GB Sciences Publishes Study on Creation of Novel | fishbrains | investorshub | 04/01/2021 5:32:19 PM |
Need new management here. | XeoX_X | investorshub | 03/17/2021 6:53:34 PM |
Yes Sir! We both agreed! | Bossman1981 | investorshub | 02/26/2021 5:20:49 PM |
That's how she moved on her way over | st007 | investorshub | 02/25/2021 9:54:34 PM |
Slow moving | Bossman1981 | investorshub | 02/12/2021 3:51:59 PM |
Is this dog dead? | wasdeafonce | investorshub | 02/06/2021 8:50:03 PM |
GW deal will fire up 420 bios... this | DropLine | investorshub | 02/03/2021 9:05:16 PM |
Lots of patent activity!!! | chattsy11 | investorshub | 01/28/2021 8:58:47 PM |
Added many times over past few months under | FairviewInvestor | investorshub | 01/26/2021 9:34:35 PM |
Still Holding Full. So much potential in 2021. | FairviewInvestor | investorshub | 01/26/2021 7:48:14 PM |
Here shaarky, shaarky... play it as you see | DropLine | investorshub | 01/26/2021 7:42:06 PM |
Please correct me if I am wrong, but | JEB11584 | investorshub | 01/12/2021 3:12:13 PM |
LAS VEGAS, NV / ACCESSWIRE / | DropLine | investorshub | 01/12/2021 2:03:00 PM |
I'm still here. I got out, but then | st007 | investorshub | 01/05/2021 8:46:55 PM |
Been holding steady in 04s. MACD turning up. $GBLX | st007 | investorshub | 01/05/2021 8:45:28 PM |
I think heading lower first to .035ish | jjr04001 | investorshub | 12/30/2020 8:23:32 PM |
Holding .04 over the past few weeks... looks | DropLine | investorshub | 12/30/2020 7:59:56 PM |
.0418 these prices are great. I may | jjr04001 | investorshub | 12/20/2020 6:24:26 PM |
I'm out. Good luck to you! | jjr04001 | investorshub | 12/09/2020 3:13:27 PM |
znewcar1: GBLX 39% v6,7M c.057 f281M H.067 morning pop S.046 then push to HOD | znewcar1 | investorshangout | 12/08/2020 10:42:06 PM |
News, Short Squeeze, Breakout and More Instantly...
LAS VEGAS, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is developing cannabis-inspired anti-inflammatory therapeutics that address Cytokine Release Syndrome (CRS) caused by viral infect...
LAS VEGAS, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and development company, is addressing the growing need for anxiety and depression medications through the development of novel, kava-inspired formulations, which...
LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Gb Sciences , Inc. (OTCQB:GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, has co-published a study in the journal Food and Chemical Toxicology that demonstrates the potential of selec...